Jade Biosciences Inc.
JBIO | NASDAQ
$14.06
-$0.18 (-1.26%)
At close: Oct 30, 2026, 4:00 PM ET
$14.55
+$0.49 (+3.51%)
Pre-market:
Nov 2, 2026, 4:01 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -8.08 | -4.50 | -2.83 | -0.76 | -0.63 | n/a | -1.31 | -0.81 | -0.54 | -13.49 | -15.66 | -19.17 |
PEG Ratio | -0.94 | -0.59 | -1.81 | 0.02 | 0.01 | n/a | -0.05 | 0.01 | -0.16 | -1.02 | -3.78 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.08 | 2.74 | 2.29 | 1.90 | 1.41 | 0.97 | 1 | 2.87 | 0.52 | 9.40 | 5.73 | 2.98 |
P/FCF Ratio | -10.98 | -8.11 | -8.03 | -4.44 | -4.62 | -3.88 | -1.15 | -3.51 | -0.66 | -15.78 | -20.54 | -23.98 |
P/OCF Ratio | -10.98 | -8.12 | -8.04 | -4.45 | -4.62 | -3.88 | -1.15 | -3.51 | -0.66 | -15.80 | -20.61 | -24.03 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 14.93 | 14.29 | 20.33 | 9.01 | 10.31 | 32.01 | 20.93 | 8.78 | 6.51 | 6.65 | 7.04 | 9.34 |
Current Ratio | 14.93 | 14.29 | 20.33 | 9.01 | 10.31 | 32.01 | 20.93 | 8.78 | 6.51 | 6.65 | 7.04 | 9.34 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -12.68% | -13.62% | -9.60% | -14.04% | -15.94% | -3.36% | -7.10% | -20.22% | -26.25% | -25.51% | -18.65% | -15.56% |
Return on Assets | -11.81% | -12.64% | -9.13% | -12.44% | -14.35% | -3.25% | -6.76% | -17.89% | -22.18% | -21.71% | -16.02% | -13.89% |
Return on Invested Capital | -13.37% | -14.62% | -10.50% | -15.21% | -13.73% | -4.49% | -8.32% | -18.45% | -27.50% | -26.83% | -20.02% | -16.88% |
Dividend Yield | n/a | n/a | n/a | n/a | 24.02% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | -212.34% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove JBIO